Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
What is Nang Kuang Pharmaceutical Co Days Payable?
Nang Kuang Pharmaceutical CoTPE:1752 -1.10%88 Days Payable is 60.15 as of Dec. 2025, which is 9% above its 10-year median of 55.10. GuruFocus rates TPE:1752 with a GF Score™ of 88/100 and a GF Value™ of NT$46.62 (Significantly Undervalued). The stock has 3 warning signs investors should review. Among 796 Medical Devices & Instruments companies, Nang Kuang Pharmaceutical Co ranks worse than 61.56% on this metric.
The historical rank and industry rank for Nang Kuang Pharmaceutical Co's Days Payable or its related term are showing as below:
TPE:1752'
s Days Payable Range Over the Past 10 Years
Min: 24.55 Med: 55.1 Max: 69.97
Current: 56.37
During the past 13 years, Nang Kuang Pharmaceutical Co's highest Days Payable was 69.97. The lowest was 24.55. And the median was 55.10.
TPE:1752's Days Payable is ranked worse than 61.56% of 796
companies
in the Medical Devices & Instruments industry
Industry Median: 67.97
vs TPE:1752: 56.37
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
TPE:1752 vs ISRG, BDX, MDLN: Days Payable Comparison
For the Medical Instruments & Supplies subindustry, Nang Kuang Pharmaceutical Co's Days Payable, along with its competitors' market caps and Days Payable data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Nang Kuang Pharmaceutical Co Days Payable vs Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, Nang Kuang Pharmaceutical Co's Days Payable distribution charts can be found below:
* The bar in red indicates where Nang Kuang Pharmaceutical Co's Days Payable falls into.
Nang Kuang Pharmaceutical Co Days Payable Calculation
Days Payable indicates the number of days that the account payable relative to cost of goods sold the company has. An increase of Days Payable may suggest that the company delays paying its suppliers.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Nang Kuang Pharmaceutical Co (TPE:1752) has a Days Payable of 60.15 as of Dec. 2025. Days payable represents the average amount of days a company waits to pay its invoices from suppliers. View historical data on Nang Kuang Pharmaceutical Co and its competitors. This is near median its historical median of 55.10. Over the past decade, Nang Kuang Pharmaceutical Co's Days Payable has ranged from 24.55 to 69.97. According to the industry distribution chart, Nang Kuang Pharmaceutical Co ranks #490 out of 796 companies in the Medical Devices & Instruments industry, placing it in the top 61.6%.
Is Nang Kuang Pharmaceutical Co's Days Payable too high?
Nang Kuang Pharmaceutical Co's current Days Payable of 60.15 is near median its 10-year median of 55.10. Over the past 10 years, this metric has ranged from a low of 24.55 to a high of 69.97. The Medical Devices & Instruments industry median Days Payable is 67.97. Nang Kuang Pharmaceutical Co's value of 60.15 is 11.5% below this industry median. Based on the distribution chart, Nang Kuang Pharmaceutical Co ranks #490 out of 796 companies in the Medical Devices & Instruments industry, which is below the industry midpoint. Overall, Nang Kuang Pharmaceutical Co has a GF Score™ of 88/100 and is considered Significantly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Nang Kuang Pharmaceutical Co's Days Payable compare to ISRG and BDX?
According to the Medical Devices & Instruments industry distribution chart, Nang Kuang Pharmaceutical Co ranks #490 out of 796 companies for Days Payable. This places Nang Kuang Pharmaceutical Co in the lower half of its industry. The industry median Days Payable is 67.97. Nang Kuang Pharmaceutical Co's value of 60.15 is 11.5% below this benchmark. Historically, Nang Kuang Pharmaceutical Co's own Days Payable has ranged from 24.55 to 69.97 over the past decade. While the company's 10-year median is 55.10 vs. the industry median of 67.97, Nang Kuang Pharmaceutical Co has consistently been below the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Days Payable for a Medical Devices & Instruments company?
The median Days Payable among Medical Devices & Instruments companies is 67.97, based on 796 companies in the industry. Companies in the top quartile (top 25%) have a Days Payable significantly above this median, while those in the bottom quartile fall well below. However, Days Payable should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Nang Kuang Pharmaceutical Co's current Days Payable of 60.15 is 11.5% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Days Payable mean?
A high Days Payable can signal that a stock is expensive relative to its fundamentals. Days payable represents the average amount of days a company waits to pay its invoices from suppliers. View historical data on Nang Kuang Pharmaceutical Co and its competitors. For the Medical Devices & Instruments industry, the median Days Payable is 67.97 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Nang Kuang Pharmaceutical Co's current Days Payable is 60.15, which is near median its own 10-year median of 55.10. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Nang Kuang Pharmaceutical Co stock overvalued right now?
Based on GuruFocus' analysis, Nang Kuang Pharmaceutical Co (TPE:1752) is currently considered Significantly Undervalued. The stock's GF Value™ is NT$46.62, compared to a current price of NT$31.35 — trading 32.8% below its estimated fair value. The current Days Payable is 60.15, which is near median its 10-year median of 55.10 and 11.5% below the Medical Devices & Instruments industry median of 67.97. Nang Kuang Pharmaceutical Co's overall GF Score™ is 88/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Days Payable calculated?
Days Payable is calculated from a company's financial statements. For Nang Kuang Pharmaceutical Co (TPE:1752), the current Days Payable is 60.15 as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Nang Kuang Pharmaceutical Co (TPE:1752) Overvalued in 2026?
Based on GuruFocus' analysis, Nang Kuang Pharmaceutical Co stock appears to be undervalued.
The current stock price of NT$31.35 is trading 32.8% below its estimated GF Value™ of NT$46.62.
GuruFocus considers Nang Kuang Pharmaceutical Co to be Significantly Undervalued.
Key valuation signals for TPE:1752:
Days Payable: 60.15 (near median its 10-year median of 55.10)
GF Value™: NT$46.62 vs. price of NT$31.35 (32.8% below fair value)
Industry Position: 11.5% below the Medical Devices & Instruments median (#490 of 796)
No single metric tells the full story. See the TPE:1752 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Nang Kuang Pharmaceutical Co Ltd is a Taiwan-based company, its subsidiaries are engaged in the manufacture, processing, and trading, and import and export of pharmaceuticals and medical devices. Its products are Cardiovascular system medications, Gastrointestinal medications, Nervous system drugs, Nutrition and Metabolism, Hospital infusion solution, blood products, Anticancer immunomodulators, Musculoskeletal system, and Others. Geographically, the company operates in Taiwan, China, Japan, the USA, and Other countries.
88GF Score
Get the complete analysis for TPE:1752
Days Payable is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
TPE:1752 has been successfully added to your 
